(RTTNews) - The Singapore stock market on Thursday snapped the three-day winning streak in which it had added more than 80 points or 1.7 percent. The Straits Times Index now rests just beneath the 5,000-point plateau although it's expected to move back to the upside again on Frid
(RTTNews) - The Singapore stock market on Thursday snapped the three-day winning streak in which it had added more than 80 points or 1.7 percent. The Straits Times Index now rests just beneath the 5,000-point plateau although it's expected to move back to the upside again on Frid
Earnings Call Insights: Cibus, Inc. (CBUS) Q1 2026 Management View “If I had to distill our message today into a single word, it would be execution,” said (Co-Founder, Interim CEO, President, COO & Director Peter Beetham), adding, “We raised significant capital over the last several months, approximately $37 million in gross proceeds across 2 public offerings. And we have immediately put that capi...
Earnings Call Insights: Cibus, Inc. (CBUS) Q1 2026 Management View “If I had to distill our message today into a single word, it would be execution,” said (Co-Founder, Interim CEO, President, COO & Director Peter Beetham), adding, “We raised significant capital over the last several months, approximately $37 million in gross proceeds across 2 public offerings. And we have immediately put that capital to work, advancing our commercial objectives for our priority programs.” (Interim CEO Beetham) framed 2026 as a commercialization year: “our focus has shifted to executing on the commercial opportunities ahead of us, getting material back into the hands of our customers, negotiating pricing and volume agreements and converting our pipeline into revenue-generating opportunities,” and highlighted, “just last week, we delivered gene edited rice with herbicide tolerant traits back to Interoc.” (Interim CEO Beetham) said partnership discussions are accelerating: “The number of active conversations, the depth of those conversations and the proximity to revenue are all meaningfully advanced from where they were when we last spoke in March,” and described the economics as: “Cibus makes the edit and Cibus retains part of the value created through royalties.” (Interim CEO Beetham) reiterated rice commercialization timelines and a U.S. shift: “we are on track for our planned 2027 initial LATAM commercial launch,” while noting, “the registration process for use of their clethodim herbicide in rice is behind the initial time line we were working against, which pushes the estimated U.S. launch from 2028 to 2029.” (Chief Scientific Officer & Executive VP Gregory Gocal) tied technical progress to scaling partnerships: “The result is a trait machine process that is faster, more scalable and more consistent than ever,” adding, “we now have the throughput to support the kind of deeper ongoing partnerships Peter outlined.” (Chief Financial Officer Carlo Broos) emphasized runway and cost ac...
Earnings Call Insights: Legacy Education (LGCY) Q3 fiscal 2026 Management View "Q3 was another strong record-breaking quarter for Legacy Education." (Founder, Chairman & CEO LeeAnn Rohmann) "Revenue increased 15% to $21.4 million." (Founder, Chairman & CEO LeeAnn Rohmann) "Adjusted EBITDA increased to $4.4 million." (Founder, Chairman & CEO LeeAnn Rohmann) "Net income increased to $3 million." (Fo...
Earnings Call Insights: Legacy Education (LGCY) Q3 fiscal 2026 Management View "Q3 was another strong record-breaking quarter for Legacy Education." (Founder, Chairman & CEO LeeAnn Rohmann) "Revenue increased 15% to $21.4 million." (Founder, Chairman & CEO LeeAnn Rohmann) "Adjusted EBITDA increased to $4.4 million." (Founder, Chairman & CEO LeeAnn Rohmann) "Net income increased to $3 million." (Founder, Chairman & CEO LeeAnn Rohmann) "During the quarter, we converted program expansion into measurable enrollment opportunities." (Founder, Chairman & CEO LeeAnn Rohmann) "We added surgical tech cohorts... generating 26 enrollments." (Founder, Chairman & CEO LeeAnn Rohmann) "And we added sterile processing... generating 49 enrollments." (Founder, Chairman & CEO LeeAnn Rohmann) "Due to delayed state approvals, it shortened our marketing runway." (Founder, Chairman & CEO LeeAnn Rohmann) "During Q3, we identified our next branch location." (Founder, Chairman & CEO LeeAnn Rohmann) "We signed a letter of intent for a facility and are finalizing the applications with the applicable state and federal regulatory agencies." (Founder, Chairman & CEO LeeAnn Rohmann) "Legacy delivered another strong quarter with continued revenue growth, increased profitability, improved educational services leverage and disciplined operating execution while funding future growth initiatives." (Chief Financial Officer Brandon Pope) "Adjusted EBITDA margin was 20.6%." (Chief Financial Officer Pope) "Bad debt expense remained consistent at 5% of revenue." (Chief Financial Officer Pope) "In Q3, our Integrity College of Health in Pasadena received a 6-year reaccreditation grant, the maximum period awarded by our accreditor ABHES." (Founder, Chairman & CEO LeeAnn Rohmann) "We recently announced a 5-year reaccreditation grant renewal for Contra Costa Medical Career College through our accreditor ACCET." (Founder, Chairman & CEO Rohmann) Outlook "As we look ahead, we believe Legacy is entering its next sta...
最近的热门游戏,大多主打一个“出乎意料”。 比如老牌动作游戏公司卡普空新作《识质存在》,把不会出错的,能提供情绪价值的东西都放进来。赛博养女儿喜不喜欢?三消爱不爱?那么买《识质存在》等于是买一送二,这都拿不下你? 一些新锐独立游戏,或者说中小型游戏开发者们,多少都有点剑走偏锋。从《愤怒的大脚》到《R.E.P.O.》,从《我们到了吗?》到《Get to work》,从《米塔》到《无人在线》,注重玩出...
Key PointsiShares Core S&P 500 ETF (IVV) offers much more affordable ownership costs with a lower expense ratio than the iShares Russell 2000 Growth ETF (IWO).
Key PointsiShares Core S&P 500 ETF (IVV) offers much more affordable ownership costs with a lower expense ratio than the iShares Russell 2000 Growth ETF (IWO).
Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for prostate cancer with a blood test can save men’s lives, but the “absolute benefit is small” and many men could face unnecessary treatment and medical complications, according to the most comprehensive study yet. In a review that analysed six trials involving nearly 800,000 me...
Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for prostate cancer with a blood test can save men’s lives, but the “absolute benefit is small” and many men could face unnecessary treatment and medical complications, according to the most comprehensive study yet. In a review that analysed six trials involving nearly 800,000 men, screening with the prostate-specific antigen (PSA) test reduced prostate cancer deaths by two for every 1,000 men screened, meaning 500 men must be screened to prevent one death from the disease. Continue reading...
Canada’s proposed free-trade agreement with Asean could help the region expand its sectors ranging from mining to manufacturing and boost Ottawa’s aim to lessen its dependence on the US as both sides seek to accelerate economic diversification, according to analysts. Canadian International Trade Minister Maninder Sidhu confirmed with Bloomberg on Tuesday during a visit to Manila that Canada was ke...
Canada’s proposed free-trade agreement with Asean could help the region expand its sectors ranging from mining to manufacturing and boost Ottawa’s aim to lessen its dependence on the US as both sides seek to accelerate economic diversification, according to analysts. Canadian International Trade Minister Maninder Sidhu confirmed with Bloomberg on Tuesday during a visit to Manila that Canada was keen to conclude separate pacts with the Association of Southeast Asian Nations and the Philippines...
Global robotics company WIRobotics (Co-CEOs Yeonbaek Lee and Yongjae Kim) announced that it has completed a KRW 95 billion (approximately USD 68 million) Series B funding round. The investment comes about two years after the company's KRW 13 billion Series A financing in March 2024 and reflects growing confidence in WIRobotics' next-generation robotics technologies and commercialization potential.
Global robotics company WIRobotics (Co-CEOs Yeonbaek Lee and Yongjae Kim) announced that it has completed a KRW 95 billion (approximately USD 68 million) Series B funding round. The investment comes about two years after the company's KRW 13 billion Series A financing in March 2024 and reflects growing confidence in WIRobotics' next-generation robotics technologies and commercialization potential.